GlassScriptPhysician profile
Matthew C Mccormack
NPI 1598810145
$3,323.42
in general payments reported to CMS, 2019-2025
14 companies · $529 in 2025
The $529 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,557 · 2020: $71.19 · 2021: $275 · 2022: $143 · 2023: $427 · 2024: $320 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081 · Travel and Lodging: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.48 |
| Travel and Lodging | $195.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,529.51 | 2019 | |
| Teleflex LLC | $369.47 | 2022-2023 | Urolift |
| Calyxo, INC. | $337.00 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $333.33 | 2020-2025 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $201.00 | 2021-2025 | |
| Boston Scientific Corporation | $171.15 | 2019-2025 | Lumenis Pulse 120h, Advantage System |
| Urogen Pharma, INC. | $92.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.00 | 2021 | |
| Astellas Pharma US INC | $70.04 | 2021 | |
| Laborie Medical Technologies Corp. | $44.07 | 2024 | Endosheath Technology |
| Allergan, INC. | $43.29 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $20.17 | 2023 | Pylarify |
| Mentor Worldwide LLC | $18.51 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Endo Pharmaceuticals INC. | $18.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mccormack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.